Niagen Bioscience Inc
USD3.21
-0.10 (-2.88%)
CEO
Robert N. Fried
IPO Date
2015-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.28
Prev. Close
$3.30
Day Low
$3.18
Day High
$3.28
52W Low
$3.18
52W High
$14.40
Market Cap
$0.26B
Volume
0.32M
| 53.1 |
| 31 Dec 2023 | FY | 60.8% | -5.9% | -17.4% | -9.0% | 0.12 | 2.40 | -20.4 |
| 31 Dec 2022 | FY | 59.4% | -23.0% | -57.7% | -30.6% | 0.15 | 2.61 | -7.0 |
| 31 Dec 2021 | FY | 61.5% | -40.2% | -85.5% | -46.9% | 0.15 | 2.78 | -9.3 |
| 31 Dec 2020 | FY | 59.5% | -33.6% | -121.3% | -51.9% | 0.10 | 1.96 | -14.7 |
| 31 Dec 2019 | FY | 55.7% | -69.4% | -157.2% | -79.9% | 0.08 | 2.23 | -7.6 |
| 31 Dec 2018 | FY | 50.9% | -105.6% | -122.6% | -78.9% | 0.01 | 2.53 | -5.7 |
| 31 Dec 2017 | FY | 49.4% | -53.7% | -21.1% | -18.1% | 0.01 | 7.07 | -24.9 |
| 31 Dec 2016 | FY | 48.0% | -13.5% | -29.4% | -14.8% | 0.06 | 1.77 | -42.2 |
| 30.4 |
| 30 Sept 2025 | Q3 | 64.5% | 13.5% | 6.5% | 4.7% | 0.04 | 4.12 | 46.6 |
| 30 Jun 2025 | Q2 | 65.0% | 11.6% | 5.6% | 3.9% | 0.05 | 3.88 | 79.1 |
| 31 Mar 2025 | Q1 | 63.4% | 16.6% | 9.1% | 6.2% | 0.06 | 3.66 | 26.5 |
| 31 Dec 2024 | Q4 | 62.5% | 24.6% | 15.6% | 10.5% | 0.06 | 3.57 | 14.2 |
| 30 Sept 2024 | Q3 | 63.5% | 7.3% | 5.5% | 3.3% | 0.08 | 2.95 | 45.6 |
| 30 Jun 2024 | Q2 | 60.2% | -0.1% | -0.0% | -0.0% | 0.10 | 2.76 | -3387.6 |
| 31 Mar 2024 | Q1 | 60.7% | -2.2% | -1.7% | -0.9% | 0.11 | 2.52 | -138.0 |
| 31 Dec 2023 | Q4 | 61.0% | 0.5% | 0.4% | 0.2% | 0.12 | 2.40 | 228.6 |